Figure 3. ROC curves in the hold-out validation process: a) training set with the 85% of the DrugBank interactions; b) test set with the 15% of the extracted DrugBank interactions; c) training set with the 70% of the DrugBank interactions; d) test set with the 30% of the extracted DrugBank interactions.